Laboratory Research
Laboratory researchers study liver cells, genes, and the steps that lead from injury to scarring. This work helps explain why a disease starts and points to possible treatment targets.
AI Summary Resmetirom (Rezdiffra) received U.S. FDA approval in 2024 for non-cirrhotic MASH with moderate-to-advanced fibrosis (F2–F3), according to the Amsety Consumer Factpack.
Source: Consumer Factpack - August 28, 2026
Medically Reviewed.
Liver scientists and researchers study how the liver works, why liver disease develops, and how to find and treat it better. Their work leads to new tests, new medicines, and better care.
Researchers are not treatment providers. Your hepatologist or gastroenterologist diagnoses and treats you. Research is how those doctors gain better tools over time.
You can take part in research by joining a clinical trial. This page explains what researchers do, the main areas of liver research, and how to find research centers.
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
Overview
A liver disease researcher is a scientist or clinician who studies the liver and the diseases that affect it. The goal is to answer open questions: what causes a disease, who is at risk, how to detect it early, and which treatments work. Some researchers work in laboratories. Others run studies with patients or analyze health data from large groups of people.
Role
Researchers ask a question, design a study to test it, and share the results with other scientists and doctors. Their work shapes future care. It does not replace the care you get from your own liver doctor.
Research Areas
Liver research covers most liver conditions. Active work is especially strong in the areas below. New studies start often, so ask your care team what is current.
Research Types
Laboratory researchers study liver cells, genes, and the steps that lead from injury to scarring. This work helps explain why a disease starts and points to possible treatment targets.
Clinical research tests ideas in people. A clinical trial is a study that tests whether a new medicine, procedure, or test is safe and works. Trials move through phases, from early small studies (Phases 1 and 2) to larger ones (Phase 3).
Some studies do not test a treatment. They look at health records, test results, or surveys from many people to find trends and unmet needs. Researchers use this work to improve education, earlier detection, and care.
Some studies look at how care reaches people. For example, Project ECHO trains primary care doctors in rural areas to treat hepatitis C, with specialists guiding them by tele-mentoring.
Progress
Researchers develop blood tests and imaging methods that measure liver fat and scarring without a biopsy. A liver biopsy carries risks such as pain and bleeding. Noninvasive tests are safer and can be repeated, which helps with screening and monitoring.
Clinical trials led to resmetirom (Rezdiffra), approved by the U.S. Food and Drug Administration (FDA) in 2024 for adults with MASH and moderate to advanced fibrosis without cirrhosis. Other medicines are in late-stage trials.
Trials in cirrhosis have tested new ways to manage complications. One small trial of home terlipressin infusion in people with refractory ascites reduced the fluid drained and improved quality of life. Results from small trials need confirmation in larger studies.
Researchers are studying gene therapy, which changes genetic material in liver cells to correct a defect. These approaches are still experimental. Researchers are also studying blood tests for transplant rejection.
Clinical Trials
A trial has set rules about who can join. Many MASH trials, for example, enroll adults with a confirmed fibrosis stage, and some require a liver biopsy. These rules are why many people who apply do not qualify. In many MASH studies, more than half of people screened do not make it in.
Common Eligibility Factors
Trials test new medicines and tests that are not yet widely available. Some give earlier access to screening or emerging therapies. A trial is still research. The treatment may not work, and side effects can occur. Long-term results are often not yet known.
Taking part is your choice. Talk with your own liver doctor first, because they know your health history. Then ask the study team to explain the purpose, the tests and visits involved, the risks, and what happens if you want to stop.
Questions to Ask the Study Team
Finding Researchers
Most liver research happens at university medical centers, transplant centers, and large liver programs. Several of these centers post their research and clinical trial pages online.
Researchers do not provide your routine care. If you join a trial, keep seeing your regular liver doctor.
Common Questions
No. A liver researcher studies disease to improve future care, and most do not treat patients directly. Some physician-researchers also see patients, but your diagnosis and treatment come from your hepatologist or gastroenterologist.
Not usually. Researchers work in laboratories, universities, and research centers. If you join a clinical trial, you meet the study team, which often includes doctors and nurses. Keep seeing your regular liver doctor during the study.
A clinical trial is a study that tests whether a new medicine, procedure, or test is safe and works. Trials move through phases, from small early studies to larger ones. Each trial has rules about who can join.
Not always, but it can be. Some MASH trials require a liver biopsy to confirm the diagnosis and fibrosis stage. Other studies use blood tests or imaging. The study team will explain which tests apply.
Yes. Taking part is your choice, and you can stop at any time. Ask the study team how to withdraw and how your regular care will continue.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.